GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial

Regulation of nutrition-associated receptors in blood monocytes of normal weight and obese humans

(2015) Olga Pivovarova et al.   PEPTIDES

Glucose-dependent insulinotropic polypeptide induces cytokine expression, lipolysis, and insulin resistance in human adipocytes

(2012) Katharina Timper et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion

(2009) G. Mingrone et al.   DIABETOLOGIA

Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes: Involvement of Nuclear Factor- B and c-Jun NH2-Terminal Kinase Pathways

(2008) P. Jiao et al.   DIABETES

Dorothy Hodgkin Lecture 2008 Gastric inhibitory polypeptide (GIP) revisited: a new therapeutic target for obesitydiabetes?

(2008) P. R. Flatt   DIABETIC MEDICINE

The incretin system and its role in type 2 diabetes mellitus

(2008) J HOLST et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Innate immunity, insulin resistance and type 2 diabetes

(2007) José Manuel Fernández-Real et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM